Individuals with mutant CCR5 are relatively resistant to HIV-1 infection and do not show apparent health problems [8, 9, 10], indicating that CCR5 is an ideal target for treatment and prevention of HIV-1 infection. Here, CCR5 is linked to HIV-1 infection.